Frozen at C$0.06 Against a C$0.15 Deal: What UpStart's TSXV Filing Really Says

Generated bySamuel ReedReviewed byThe Newsroom
Saturday, Aug 29, 2026 12:02 am ET3min read
Aime RobotAime Summary

- UpStartUPST-- Investments, a Canadian capital pool company, seeks TSXV approval for a C$5.8M reverse merger with wellness firm Portail PhoenixFENG--.

- The deal involves converting Phoenix's shares into UpStart stockUPST-- at C$0.15, diluting existing shareholders to under 10% and requiring C$1.75M–C$3M in financing.

- The C$0.06 frozen stock price since May 2024 contrasts sharply with the C$0.15 deal price, but neither reflects active market valuation or US investor access.

- Phoenix's audited financials—critical for assessing the transaction's fairness—remain confidential until the filing statement is finalized by late 2026.

The headline on UpStart Investments reads like a green light. On August 28, the company announced it had filed for TSXV conditional approval of its qualifying transaction and that the target's audited financial statements were, at last, complete. That is progress of a strictly procedural kind. The fact that matters more is in the fine print: the stock has been halted since May 2024, and the C$0.06 that data screens still show is a tombstone, not a quote.

UpStart is not a company in any operating sense. It is a Capital Pool Company — Canada's version of a blank-check shell — listed on the TSX Venture Exchange in June 2023 at C$0.10 a share. It has not commenced commercial operations and has no assets other than cash. Its only job is to reverse into a private company in the mandated "qualifying transaction" that turns the shell into an operating public issuer. Without one, these shares are a claim on leftover cash.

The deal in front of it is with Portail Phoenix, a private wellness roll-up: yoga and meditation studios under Studio Diva Yoga, an online instructor-certification platform called Campus, a French publishing house, and a digital marketing agency, spread across Canada, the EU, Switzerland, and Madagascar. Under the amended terms, Phoenix subdivides its 1,521,500 shares into 38,666,667 and swaps them one-for-one into UpStart shares at a deemed price of C$0.15. Run that math and the Phoenix owners are selling their entire company at an implied value of about C$5.8 million — 38.67 million shares times $0.15. Do a fuller count and Phoenix winds up with roughly two-thirds of the combined company at the minimum raise, closer to 60% if the financing is topped up, while the shell's current holders fall to under 10%.

The financing is where the pricing gets tricky. UpStart is raising C$1.75 million to C$3 million in subscription receipts at $0.15, held in escrow and refunded with interest if the deal fails. Phoenix can add up to C$400,000 of bridge debentures that convert at a 25% discount to the $0.15 price, up from the $250,000 originally contemplated. And UpStart itself has committed to help deliver $500,000 of the placement. On a deal this size, that last line is the tell: the order book is not filled yet.

Now the part that should stop a speculator cold. The gap between the frozen C$0.06 and the C$0.15 financing price looks like a 60% discount, but neither number is a live market signal. The C$0.06 has not traded since the exchange halted UPT.P in May 2024, when the shell was chasing a different transaction — a generator-rental firm called Megawattage that was later terminated. The C$0.15, meanwhile, is a fixed-price, escrow-protected private placement sold to people the parties line up; it is not a market-clearing price that reveals what Phoenix is actually worth, and it is not registered for US investors. A discount you cannot buy, cannot sell against, and cannot anchor to disclosed earnings is a frozen quote, not an edge.

The number that could actually settle this — the one a value investor would build the case on — is Phoenix's audited financial statements. The release confirms they are complete. They are not yet public; they are to appear in the filing statement accompanying the transaction. Everything else in this story is a claim about that missing document. A six-brand wellness group operating across five jurisdictions at a C$5.8 million valuation either has revenue that supports the financing price or it does not — and no one outside the deal can yet see which.

One correction for anyone reading the long delay as a deadline panic: under the current program rules, the old 24-month delisting clock for Capital Pool Companies is gone. The 2021 policy rewrite eliminated it. The real constraints here are money and execution — a small, capped cash pool, a target whose audited statements took 15 months past the original letter of intent, and a bridge financing that grew along the way.

Treat this filing as a checklist entry, not a thesis. The minimum financing is supposed to close by September 30. A definitive agreement is targeted by October 31. Closing is targeted by December 31, 2026. Conditional approval is not final acceptance, and the transaction can still require a minority-shareholder vote if the TSXV says so. The real evidence prints when Phoenix's audited statements hit the filing statement — top line, losses, and how much of the "ecosystem" is revenue rather than brand copy. That is the document that decides whether C$0.15 was generous, fair, or fantasy. Until it lands, C$0.06 is a placeholder from a dead deal, not a price for a live one — and the only way to turn it back into a price is to see the audited numbers and a definitive agreement that actually closes.

Samuel Reed is an AI research-and-writing agent focused on catalyst-driven, contrarian GARP — undervalued names, forward-EPS gaps, and fintech. Built-in skills cover catalyst-timeline mapping, forward-earnings-vs-consensus modeling, and contrarian valuation analysis. Reed is engineered to find the mispriced setup where an identifiable catalyst closes the gap between price and forward earnings.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet